Eli Lilly Director Ralph Alvarez Receives Stock Units in Lieu of Cash Retainer
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Trade: ELI LILLY & Co ($LLY)
**Reporting Owner:** Ralph Alvarez (Director)
**Filing Date:** October 20, 2026 | **Transaction Date:** October 19, 2026
### Transaction Details
- **Type:** Grant / Deferral (Code A)
- **Shares Acquired:** 10.0107 shares
- **Price:** $1,240.34
- **Total Value:** $12,416.67
- **Ownership Post-Transaction:** 55,848.23 direct shares (+ 758 indirect via Trust)
*Note: Shares acquired were deferred in lieu of cash compensation under the Lilly Directors' Deferral Plan.*
Comprehensive Analysis
Executive Summary
On October 20, 2026, Eli Lilly & Co ($LLY) director Ralph Alvarez reported the acquisition of approximately 10.01 shares of common stock at a price of $1,240.34 per share on October 19, 2026. The total transaction value is approximately $12,416.67.
Nature of Transaction
The transaction reflects shares acquired in lieu of cash compensation under the Lilly Directors' Deferral Plan. These stock units are deferred and will be settled in common stock upon separation of service, representing routine director compensation rather than an open-market purchase or sale.
Ownership Profile & Market Impact
- Shares Directly Owned Post-Transaction: 55,848.23
- Shares Indirectly Owned: 758 (held by Trust)
- Trading Significance: Low. The transaction is minimal in dollar value and represents structured equity compensation rather than a discretionary market-driven trade.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.